Investigators at Washington University School of Medicine in St. Louis identified a compound that can help sensory neurons in the central nervous system to heal.
In a roundup review of scientific studies recently published, a study out of RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) in Ireland further defined the association between comorbidities and poor outcomes with Covid-19.
Abbott Laboratories’ antibody test for the new coronavirus is highly likely to correctly determine whether people have ever been infected with the fast-spreading virus, the company said, citing a U.S. study.
A specially designed clinical study that was the first disease prevention trial to study Alzheimer’s disease drugs with different mechanisms of action from two different pharmaceutical companies failed to hit the primary endpoint.
Breast Cancer: Steady Progress Being Made in New Treatments
Antigens, Breast Cancer, Cancer Cells, Checkpoint Inhibitors, Clinical Data, Clinical Trials, Genetics, HER2-positive breast cancer, Postmenopausal, R&D, T-Cells, U.S. Centers for Disease Control and Prevention, Washington University School of Medicine in St. LouisFor Breast Cancer Awareness Month, BioSpace gathered examples of recent breakthroughs in breast cancer treatment.
More Research Links Immune Cells to Alzheimer’s Disease
Alzheimer’s disease, Beta-Amyloid Protein, Brain Damage, Immune Cells, Immune Response, Immune System, Journal of Experimental Medicine, Microglial Cells, Neurodegeneration, Neurons, Researchers, Tau, Washington University School of Medicine in St. LouisResearchers at Washington University School of Medicine in St. Louis found further evidence that microglia are the key link between the accumulation of abnormal proteins, including beta-amyloid and tau, in the brain and the actual brain damage observed in Alzheimer’s patients.